Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kaye

Showing results (11-20 of 418) with videos related to

Pageof 42
Sort By:
Coronary Artery Disease|January 25, 2003
Neurohormonal assessment of cardiac functionAnuradha Aggarwal, David M Kaye
International Journal of Cardiology|November 2, 2010
Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fractionMicha T Maeder, David M Kaye
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Cardiac Gene Delivery Using Recirculating DevicesMelissa J Byrne, David M Kaye
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 15, 2008
Re: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantationDavid M Kaye, Murray D Esler
Southern Medical Journal|December 18, 2008
B-type natriuretic peptide in end-stage renal disease: a neurohormone rather than a volume status monitorMicha T Maeder, David M Kaye
Journal of Cardiovascular Translational Research|June 19, 2010
Delivery of gene and cellular therapies for heart diseaseJustin A Mariani, David M Kaye
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Does arginase activity in vitro represent that in vivo?Wei-Zheng Zhang, David M Kaye
Analytical Biochemistry|February 11, 2004
Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatizationWei-zheng Zhang, David M Kaye
Journal of the American College of Cardiology|March 14, 2009
Heart failure with normal left ventricular ejection fractionMicha T Maeder, David M Kaye
JACC. Cardiovascular Imaging|April 17, 2017
Impaired Right Heart and Pulmonary Vascular Function in HFpEF: Time for More Risk Markers?David M Kaye, Thomas H Marwick
Pageof 42

Showing results (11-20 of 418) with videos related to

Sort By:
Pageof 42
Coronary Artery Disease|January 25, 2003
Neurohormonal assessment of cardiac functionAnuradha Aggarwal, David M Kaye
International Journal of Cardiology|November 2, 2010
Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fractionMicha T Maeder, David M Kaye
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Cardiac Gene Delivery Using Recirculating DevicesMelissa J Byrne, David M Kaye
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 15, 2008
Re: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantationDavid M Kaye, Murray D Esler
Southern Medical Journal|December 18, 2008
B-type natriuretic peptide in end-stage renal disease: a neurohormone rather than a volume status monitorMicha T Maeder, David M Kaye
Journal of Cardiovascular Translational Research|June 19, 2010
Delivery of gene and cellular therapies for heart diseaseJustin A Mariani, David M Kaye
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Does arginase activity in vitro represent that in vivo?Wei-Zheng Zhang, David M Kaye
Analytical Biochemistry|February 11, 2004
Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatizationWei-zheng Zhang, David M Kaye
Journal of the American College of Cardiology|March 14, 2009
Heart failure with normal left ventricular ejection fractionMicha T Maeder, David M Kaye
JACC. Cardiovascular Imaging|April 17, 2017
Impaired Right Heart and Pulmonary Vascular Function in HFpEF: Time for More Risk Markers?David M Kaye, Thomas H Marwick
Pageof 42